Trellus Management Company, LLC Cidara Therapeutics, Inc. Transaction History

Trellus Management Company, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 31, 2019	SELL	$1.49 - $2.94 $140,273 - $276,780	-94,143 Closed	0 $0
Q4 2018 Feb 04, 2019	BUY	$2.1 - $4.5 $101,621 - $217,759	48,391 Added 105.77%	94,143 $221,000
Q1 2018 May 02, 2018	SELL	$4.0 - $8.15 $60,836 - $123,953	-15,209 Reduced 24.95%	45,752 $183,000
Q4 2017 Feb 02, 2018	BUY	$6.35 - $8.75 $133,102 - $183,408	20,961 Added 52.4%	60,961 $415,000
Q3 2017 Oct 19, 2017	BUY	$5.75 - $8.1 $230,000 - $324,000	40,000	40,000 $324,000

Ticker CDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,075,696
Market Cap $1.43B
Description
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...

Get notified when there are updates to the investment portfolio of Trellus Management Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Trellus Management Company, LLC with notifications on news.